177 related articles for article (PubMed ID: 20027675)
1. Reduced normogastric electrical activity associated with emesis: a telemetric study in ferrets.
Percie du Sert N; Chu KM; Wai MK; Rudd JA; Andrews PL
World J Gastroenterol; 2009 Dec; 15(48):6034-43. PubMed ID: 20027675
[TBL] [Abstract][Full Text] [Related]
2. Using telemetry to automate the detection of emesis in the ferret: new vistas for delayed emesis assessment.
Goineau S; Rompion S; Guillaume P; Barrais L; Castagné V
J Pharmacol Toxicol Methods; 2013; 68(1):160-5. PubMed ID: 23578691
[TBL] [Abstract][Full Text] [Related]
3. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three preclinical models for nausea and vomiting assessment.
Goineau S; Castagné V
J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617
[TBL] [Abstract][Full Text] [Related]
5. The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret.
Percie du Sert N; Rudd JA; Moss R; Andrews PL
Neurosci Lett; 2009 Nov; 465(1):16-20. PubMed ID: 19733218
[TBL] [Abstract][Full Text] [Related]
6. Centrally located GLP-1 receptors modulate gastric slow waves and cardiovascular function in ferrets consistent with the induction of nausea.
Lu Z; Yeung CK; Lin G; Yew DTW; Andrews PLR; Rudd JA
Neuropeptides; 2017 Oct; 65():28-36. PubMed ID: 28456436
[TBL] [Abstract][Full Text] [Related]
7. Gastric myoelectric activity during cisplatin-induced acute and delayed emesis reveals a temporal impairment of slow waves in ferrets: effects not reversed by the GLP-1 receptor antagonist, exendin (9-39).
Lu Z; Ngan MP; Lin G; Yew DTW; Fan X; Andrews PLR; Rudd JA
Oncotarget; 2017 Nov; 8(58):98691-98707. PubMed ID: 29228720
[TBL] [Abstract][Full Text] [Related]
8. Differential hypoglycaemic, anorectic, autonomic and emetic effects of the glucagon-like peptide receptor agonist, exendin-4, in the conscious telemetered ferret.
Lu Z; Percie Du Sert N; Chan SW; Yeung CK; Lin G; Yew DT; Andrews PL; Rudd JA
J Transl Med; 2014 Dec; 12():327. PubMed ID: 25491123
[TBL] [Abstract][Full Text] [Related]
9. Post-anesthesia vomiting: impact of isoflurane and morphine on ferrets and musk shrews.
Horn CC; Meyers K; Pak D; Nagy A; Apfel CC; Williams BA
Physiol Behav; 2012 Jun; 106(4):562-8. PubMed ID: 22504494
[TBL] [Abstract][Full Text] [Related]
10. Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets.
Yamakuni H; Sawai-Nakayama H; Imazumi K; Maeda Y; Matsuo M; Manda T; Mutoh S
Eur J Pharmacol; 2002 May; 442(3):273-8. PubMed ID: 12065081
[TBL] [Abstract][Full Text] [Related]
11. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret.
Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Rudd JA
Neuropharmacology; 2010 Feb; 58(2):383-91. PubMed ID: 19825380
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced gastric dysrhythmia and emesis in dogs and possible role of gastric electrical stimulation.
Yu X; Yang J; Hou X; Zhang K; Qian W; Chen JD
Dig Dis Sci; 2009 May; 54(5):922-7. PubMed ID: 18754094
[TBL] [Abstract][Full Text] [Related]
13. Automated analysis of delayed emesis in the telemetered ferret: detection of synergistic effects of aprepitant and ondansetron.
Goineau S; Guillaume P; Barrais L; Castagné V
Fundam Clin Pharmacol; 2014 Dec; 28(6):643-51. PubMed ID: 24750138
[TBL] [Abstract][Full Text] [Related]
14. Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine.
Foss JF; Yuan CS; Roizen MF; Goldberg LI
Cancer Chemother Pharmacol; 1998; 42(4):287-91. PubMed ID: 9744773
[TBL] [Abstract][Full Text] [Related]
15. Sulprostone-Induced Gastric Dysrhythmia in the Ferret: Conventional and Advanced Analytical Approaches.
Lu Z; Zhou Y; Tu L; Chan SW; Ngan MP; Cui D; Liu YHJ; Huang IB; Kung JSC; Hui CMJ; Rudd JA
Front Physiol; 2020; 11():583082. PubMed ID: 33488391
[TBL] [Abstract][Full Text] [Related]
16. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA
Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289
[TBL] [Abstract][Full Text] [Related]
17. The antiemetic activity of granisetron against cytostatic-treatment-induced emesis in 10- to 13-week-old ferrets.
Marr HE; Davey PT; Boyle EA; Blower PR
J Cancer Res Clin Oncol; 1994; 120(4):204-7. PubMed ID: 8288674
[TBL] [Abstract][Full Text] [Related]
18. Olvanil, a non-pungent vanilloid enhances the gastrointestinal toxicity of cisplatin in the ferret.
Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Lin G; Rudd JA
Toxicol Lett; 2010 Feb; 192(3):402-7. PubMed ID: 19931602
[TBL] [Abstract][Full Text] [Related]
19. Action of metyrapone and tetracosactrin to modify cisplatin-induced acute and delayed emesis in the ferret.
Sam TS; Kan KK; Ngan MP; Rudd JA; Yeung JH
Eur J Pharmacol; 2003 Apr; 466(1-2):163-8. PubMed ID: 12679153
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-induced emesis in the Ferret: a new animal model.
Florczyk AP; Schurig JE; Bradner WT
Cancer Treat Rep; 1982 Jan; 66(1):187-9. PubMed ID: 7198011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
